INFLUENCE OF REGULATORY MEASURES AND MARKET POLICY FOR REIMBURSED MEDICINAL PRODUCTS ON THE VALUE, PAID WITH PUBLIC FUNDS IN BULGARIA IN 2015

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 6

Abstract

In Bulgaria large number of medicines yearly are included and excluded from Positive Drug List (PDL). It leads to different changes in the value per DDD paid with public funds (reference value) and utilization of medicines. The goal of the study is to analyze the main results from market policy of inclusion and exclusion of medicines in PDL as well as other factors leading to changes in reference value per DDD for all reimbursed medicines. The study is retrospective and observational analysis of Annex 1 and Annex 2 of Positive Drug List (PDL) in 2015. The changes in reference value per DDD, the rate of the decreasing or increasing of value were observed for all therapeutic groups in Annex 1 and Annex 2, where new medicines are included or excluded. We found that 109 new trademarks (belonging to 53 INNs), as well as 15 fixed dose combinations (belonging to 7 INN) in 2015 were included in Annex 1. 149 new trademarks, belonging to 67 INNs, were included in Annex 2, along with 16 fixed dose combinations (belonging to 7 INN). The number of excluded medicines is 60, belonging to 57 INNs from Annex 1, and 90 trademarks belonging to 85 INNs from Annex 2. On total the number of medicines in which the reference value is reduced is higher than medicines with the unchanged prices. The leading factor for decreasing the reference value in 2015 is a change of the price of the medicinal product within the group. It is mainly due to external reference comparison but also to generic and therapeutic competition. The next reason leading to decreasing the value is inclusion in PDL of generic medicines with lower prices.

Authors and Affiliations

Z. Mitkova

Keywords

Related Articles

RISK FACTORS, CAUSES AND OUTCOME OF POSTPARTUM HEMORRHAGE IN SULAIMANIA MATERNITY TEACHING HOSPITAL

Postpartum hemorrhage (PPH) is still one of the leading causes of maternal morbidity and mortality. Blood loss in excess of 500ml after vaginal delivery or 1000 after C/S in the first 24 hours, is defined as primary PPH,...

CHEMICAL-QUANTUM ANALYSIS OF THE AGGRESSIVENESS OF GLUCOSE AND ITS APPEASEMENT WITH ATP INSIDE THE CELL, AND WATER AS AN EXCELLENT ANTIOXIDANT

Glucose (GLU) is the molecule that provides energy for all our biological functions. Insulin controls the GLU in the bloodstream until it is introduced into the cell. The objective of this work was to investigate which b...

A REVIEW ON ANTI-TUBERCULOSIS DRUGS POSSESSING VARIOUS PHARMACOLOGICAL AND BIOLOGICAL EVALUATION

Tuberculosis (TB) is an ancient disease with high incidence and mortality rates in Africa and Asian countries. This can be because of Multidrug resistant (MDR) TB, extensively drug resistant (XDR) TB and human immunodefi...

PREMATURE EVENTS IN CHIKUNGUNYA VIRUS INFECTION AND THEIR INHIBITING STRATEGIES—FROM VIRUS CELL BINDING TO MEMBRANE FUSION

Chikungunya virus is a rapidly emerging mosquito-borne alphavirus causing millions of infections in the tropical and subtropical regions of the world. This infection often leads to an acute self-limited febrile illness w...

EVALUATION OF CAMPYLOBACTER CONTAMINTION IN POULTRY HOUSES AND POULTRY SLAUGHTERHOUSES IN BAHRI LOCALITY – SUDAN

This study was carried out during the period from April to June 2017 in Bahri locality, Sudan. The overall objective of this study is to evaluate the hygienic biosecurity practices designed to control campylobacter conta...

Download PDF file
  • EP ID EP618207
  • DOI -
  • Views 119
  • Downloads 0

How To Cite

Z. Mitkova (2017). INFLUENCE OF REGULATORY MEASURES AND MARKET POLICY FOR REIMBURSED MEDICINAL PRODUCTS ON THE VALUE, PAID WITH PUBLIC FUNDS IN BULGARIA IN 2015. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 6(6), 19-31. https://europub.co.uk/articles/-A-618207